{"id":"W3014213633","doi":"10.1017/cjn.2019.111","title":"P.010 Efficacy, safety, and tolerability of ubrogepant for the acute treatment of migraine: a single-attack phase 3 study, ACHIEVE II","year":2019,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Placebo; Migraine; Medicine; Nausea; Somnolence; Clinical endpoint; Population; Adverse effect; Anesthesia; Phases of clinical research; Internal medicine; Randomized controlled trial; Clinical trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001296955,0.0006241968,0.001105779,0.0002179804,0.0002854455,0.0006231864,0.0004595141,0.0006715059,0.01170442],"category_scores_gemma":[0.0009173082,0.0002880237,0.00091756,0.0002185961,0.0005120921,0.0003784784,0.0002371923,0.001776085,0.001758855],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002977639,"about_ca_system_score_gemma":0.0009539125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002800606,"about_ca_topic_score_gemma":0.0006226514,"domain_scores_codex":[0.9996568,0.0001675028,0.00002098634,0.00004749095,0.00005427901,0.00005304794],"domain_scores_gemma":[0.9994084,0.0001406169,0.000180703,0.00005170581,0.00005857779,0.000159953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8469988,0.01882844,0.004005027,0.00121643,0.001071421,0.0001913071,0.0001463471,0.0005647091,0.0377795,0.0003918878,0.007141233,0.08166498],"study_design_scores_gemma":[0.620854,0.3491255,0.01625082,0.00008435145,0.0007393488,0.0003181419,0.00003670595,0.000989468,0.004877392,0.0003395727,0.006364614,0.00002016139],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977767,0.003048077,0.001935444,0.0007222583,0.0002028812,0.004916619,0.003078459,0.0003252919,0.008003947],"genre_scores_gemma":[0.9779544,0.001388655,0.00420007,0.001235328,0.0003391614,0.004422563,0.002696687,0.00009799651,0.007665195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01170442,"threshold_uncertainty_score":0.03915519,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06675388963280884,"score_gpt":0.3416765579598258,"score_spread":0.274922668327017,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}